ATC-Gruppen
- L01EC BRAF-Serin-Threoninkinase-Inhibitoren
- L01EC01 Vemurafenib
- L01EC02 Dabrafenib
- L01EC03 Encorafenib
- L01ED Anaplastische Lymphomkinase (ALK)-Inhibitoren
- L01ED01 Crizotinib
- L01ED02 Ceritinib
- L01ED03 Alectinib
- L01ED04 Brigatinib
- L01ED05 Lorlatinib
- L01EE Mitogen-aktivierte Proteinkinase (MEK)-Inhibitoren
- L01EE01 Trametinib
- L01EE02 Cobimetinib
- L01EE03 Binimetinib
- L01EE04 Selumetinib
- L01EF Cyclin-abhängige Kinasen (CDK)-Inhibitoren
- L01EF01 Palbociclib
- L01EF02 Ribociclib
- L01EF03 Abemaciclib
- L01EG Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren